Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) pour Attention & Focus Difficulties

C

Research suggests omega-3 supplementation may help improve attention and reduce impulsivity. Benefits appear more pronounced in individuals with lower baseline omega-3 levels.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dattention\u002Dfocus'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

En conclusion

Research suggests omega-3 supplementation may help improve attention and reduce impulsivity. Benefits appear more pronounced in individuals with lower baseline omega-3 levels.

Key Study Findings

Other
An HPLC-MS-Based Method for Determination of the D- and L- 5-Methyltetrahydrofolate Isomer Ratio in Dietary …
Dose: None vs: None Outcome: separation and quantification of D- and L-5-MTHF diastereomers … Effet: None None

Population: None

Review n=321
Current Evidence of Ergogenic and Post-Exercise Recovery Effects of Dietary Supplementation with Cordyceps militaris in …
Dose: None vs: None Outcome: None Effet: None None

Population: healthy individuals aged 16-35 from 5 intervention studies (2017-2024)

Other
Choline in Pediatric Nutrition: Assessing Formula, Fortifiers and Supplements Across Age Groups and Clinical Indications.
Dose: None vs: None Outcome: Choline content assessment across pediatric products Effet: None None

Population: Preterm/term infants and children with CF/kidney disease

Systematic Review
Impact of Vegan and Vegetarian Diets on Neurological Health: A Critical Review.
Dose: None vs: None Outcome: Neurological health outcomes Effet: None None

Population: None

Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None vs: None Outcome: None Effet: None None

Population: None

Meta-Analysis
The Effect of Dietary Supplements on Male Infertility in Terms of Pregnancy, Live Birth, and …
Dose: None vs: Placebo Outcome: Pregnancy, live birth, sperm parameters Effet: None None

Population: Infertile males (50 RCTs, >=12 weeks)

Key Statistics

10

Études

1800

Participants

Positive

C

Note

Referenced Papers

Newborn (Clarksville, Md.) 2024 9 citations
Indian dermatology online … 2021 17 citations
Journal of pain … 2020 56 citations
Psychiatrike = Psychiatriki 2020 15 citations
Clinical pharmacokinetics 2018 128 citations
Nutricion hospitalaria 2018 32 citations
Stem cell investigation 2017 27 citations
Ageing research reviews 2016 142 citations
Cannabis and cannabinoid … 2016 77 citations
Journal of analytical … 2016 49 citations
Child and adolescent … 2014 42 citations
Advances in nutrition … 2013 155 citations
American journal of … 2011 17 citations
European review for … 2011 9 citations
The Cochrane database … 2009 299 citations
The Cochrane database … 2007 375 citations
Sleep medicine reviews 2007 150 citations
International journal of … 2005 22 citations
Journal of clinical … 2004 205 citations
The Cochrane database … 2003 263 citations
Journal of Alzheimer's … 2003 161 citations
Neurochemical research 2003 82 citations
The British journal … 2001 166 citations
Pharmacological research 1999 1060 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:
1,000-1,700 mg/day (optimal dose-response curve)

Limite supérieure : 3,000 mg/day combined DHA/EPA (FDA GRAS)

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Neutral --
None -- Mixed 321
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
1000 mg ferric carboxymaltose -- Positive 58
None -- Mixed --

Moment optimal de prise : With meals containing fat for better absorption

Safety & Side Effects

Effets indésirables signalés

  • Fishy aftertaste or burping
  • Mild gastrointestinal discomfort
  • Potential increased bleeding time at very high doses
  • May lower blood pressure slightly

Interactions connues

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)

Apport maximal tolérable : 3,000 mg/day combined DHA/EPA (FDA GRAS)

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with Attention & Focus Difficulties?
Based on 10 studies with 1,800 participants, there is limited but promising evidence that Omega-3 Fatty Acids (DHA/EPA) may support Attention & Focus Difficulties management. Our evidence grade is C (Some Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Attention & Focus Difficulties?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Attention & Focus Difficulties?
We rate the evidence as Grade C (Some Evidence). This rating is based on 10 peer-reviewed studies with 1,800 total participants. The overall direction of effect is positive.

Related Evidence

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.